Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A (Patricia Allen/EU-Startups)

Patricia Allen / EU-Startups:
Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A  —  Pharmatech startup Aqemia has just raised €30 million in a new funding round.  The Parisian startup is generating a pioneering drug discovery pipeline …

Related Articles

Colorado-based ColdQuanta, which uses cold atom tech to build and integrate quantum computers, sensors, clocks, and networks, raised a $110M Series B (Daniel Levi/Tech Startups)

Daniel Levi / Tech Startups:
Colorado-based ColdQuanta, which uses cold atom tech to build and integrate quantum computers, sensors, clocks, and networks, raised a $110M Series B  —  The internet has changed over the years.  But the groundwork for today’s internet was laid in 1973 by the U.S. Defense Advanced Research Projects Agency (DARPA).

Paris-based Zenchef, which offers restaurants tools to enhance customer experience and optimize front-of-house operations, has raised €50M+ from PSG Equity (Patricia Allen/EU-Startups)

Patricia Allen / EU-Startups:
Paris-based Zenchef, which offers restaurants tools to enhance customer experience and optimize front-of-house operations, has raised €50M+ from PSG Equity  —  Restaurant tech player Zenchef has raised over €50 million from PSG Equity as it consolidates its position as a European leader in this space.

IBM announces its Osprey quantum processor with 433 qubits, up from 127 qubits in the 2021 Eagle processor, and plans to hit 4,000 qubits by 2025 (Frederic Lardinois/TechCrunch)

Frederic Lardinois / TechCrunch:
IBM announces its Osprey quantum processor with 433 qubits, up from 127 qubits in the 2021 Eagle processor, and plans to hit 4,000 qubits by 2025  —  IBM wants to scale up its quantum computers to over 4,000 qubits by 2025 — but we’re not quite there yet.  For now, we have to make do with …

How AI-based natural language processing algorithms can be applied to biological data to create protein-language models and cut drug discovery time to months (Karen Hao/Wall Street Journal)

Karen Hao / Wall Street Journal:
How AI-based natural language processing algorithms can be applied to biological data to create protein-language models and cut drug discovery time to months  —  Natural language processing algorithms like the ones used in Google searches and OpenAI’s ChatGPT promise to slash the time required to bring medications to market

How AI-based natural language processing algorithms can be applied to biological data to create protein-language models and cut drug discovery time to months (Karen Hao/Wall Street Journal)

Karen Hao / Wall Street Journal:
How AI-based natural language processing algorithms can be applied to biological data to create protein-language models and cut drug discovery time to months  —  Natural language processing algorithms like the ones used in Google searches and OpenAI’s ChatGPT promise to slash the time required to bring medications to market

An overview of trends from YC’s Demo Day for Summer 2022: enterprise made up the bulk at 39% of the 223 startups in the batch, followed by fintech and dev tools (Biz Carson/Protocol)

Biz Carson / Protocol:
An overview of trends from YC’s Demo Day for Summer 2022: enterprise made up the bulk at 39% of the 223 startups in the batch, followed by fintech and dev tools  —  Hello, and welcome to Pipeline.  I’m Biz Carson, and I once slept on the street overnight in London to be in the front row …